Ir para o conteúdo principal

Grafa News and Videos — Page 1082

Destaques de Grafa

Grafa

Aligos Therapeutics secures $445M licensing deal with Amoytop for HBV candidate in China

Aligos Therapeutics (NASDAQ:ALGS), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for viral and liver diseases, announced on April 16, 2026, that it has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech.

Leia mais: Aligos Therapeutics secures $445M licensing deal with Amoytop for HBV candidate in China

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas